Kynurenines in neurodegenerative disorders: therapeutic consideration.
D015526:AIDS Dementia Complex / Q000378:metabolism; D000818:Animals; D002493:Central Nervous System Diseases / Q000378:metabolism; D004314:Down Syndrome / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006801:Humans; D066298:In Vitro Techniques; D007511:Ischemia / Q000378:metabolism; D007737:Kynurenine / Q000031:analogs & derivatives / Q000737:chemistry / Q000378:metabolism*; D009103:Multiple Sclerosis / Q000378:metabolism; D019636:Neurodegenerative Diseases / Q000188:drug therapy / Q000378:metabolism* / Q000503:physiopathology; D011355:Prodrugs / Q000627:therapeutic use; D012559:Schizophrenia / Q000378:metabolism
D004791:Enzyme Inhibitors; D011355:Prodrugs; D007737:Kynurenine